Company news
Lantern Pharma Inc. news in 2020
Lantern Pharma Inc.'s news releases, calls and decks from 2020, newest first.
Lantern Pharma Announces Collaboration with World Leading Brain Cancer Program at Johns Hopkins to Further Develop LP-184 as Therapy for Glioblastoma
December 16, 2020
Lantern Pharma Announces Scientific & Preclinical Data Indicating Blood Brain Barrier Permeability for Drug Candidate LP-184 in Glioblastoma and Potentially Other CNS Cancers
December 14, 2020
Lantern Pharma Announces Upcoming Conference Presentations
November 23, 2020
Lantern Pharma Reports Third Quarter 2020 Financial Results & Continued Operational Progress
October 28, 2020
Lantern Pharma Advances Prostate Cancer Drug Development Research Collaboration with Georgetown University for LP-184, a Next-Generation, Targeted DNA-Damaging Agent
October 4, 2020
Lantern Pharma Announces Collaboration and Research Agreement with Fox Chase Cancer Center Focused on Advancing the Development of LP-184 in Pancreatic Cancer
September 21, 2020
Lantern Pharma Reports Second Quarter 2020 Financial Results and Continued Corporate Progress
July 29, 2020
Lantern Pharma Announces Two Presentations at American Association for Cancer Research (AACR) 2020 Virtual Annual Meeting
June 16, 2020
Lantern Pharma Announces Closing of Initial Public Offering
June 14, 2020
Calls in 2020
Decks in 2020
- Q3 2020 Earnings Presentation
Earnings · 17 slides · Oct 29, 2020
- Q2 2020 Earnings Presentation
Earnings · 15 slides · Jul 30, 2020
- IPO Roadshow (May 2020)
IPO roadshow · 38 slides · May 19, 2020